✦ LIBER ✦

Impact of the CYP2C19*17 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Proton Pump Inhibitors

✍ Scribed by Mazer-Amirshahi, Maryann; van den Anker, John

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of CYP2C19 Genetic Polymorphism o

✍ Cho, Hoon; Choi, Min-Koo; Cho, Doo-Yeon; Yeo, Chang-Woo; Jeong, Hye-Eun; Shon, J 📂 Article 📅 2012 🏛 Sage Publications 🌐 English ⚖ 273 KB

Effect of CYP2C19 *2 and *17 mutations o

✍ Nicole G. Hunfeld; Ron A. Mathot; Daan J. Touw; Ron H. Van Schaik; Paul G. Mulde 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 703 KB

CLOPIDOGREL PHARMACOKINETICS AND PHARMAC

✍ Andrew L. Frelinger III; Deepak L. Bhatt; Ronald D. Lee; Darcy J. Mulford; Jingt 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Dose of Proton Pump Inhibitors and the C

📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

CYP2C19 Genotype and Pharmacokinetics of

✍ Toshiyuki Sakai; Nobuo Aoyama; Tomoko Kita; Toshiyuki Sakaeda; Kohshi Nishiguchi 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 163 KB

Impact ofCYP2C19polymorphisms on the cli

✍ Ulrich Klotz 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 59 KB